Vanguard Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.87B | Sell |
14,716,173
-178,502
| -1% | -$82.9M | 0.1% | 176 |
|
|
2025
Q3 | $6.35B | Sell |
14,894,675
-580,889
| -4% | -$225M | 0.1% | 191 |
|
|
2025
Q2 | $5.93B | Sell |
15,475,564
-276,005
| -2% | -$99.5M | 0.1% | 192 |
|
|
2025
Q1 | $5.44B | Sell |
15,751,569
-76,857
| -0.5% | -$24.7M | 0.1% | 193 |
|
|
2024
Q4 | $4.75B | Sell |
15,828,426
-189,518
| -1% | -$66.2M | 0.08% | 225 |
|
|
2024
Q3 | $6.51B | Sell |
16,017,944
-821,571
| -5% | -$301M | 0.12% | 153 |
|
|
2024
Q2 | $5.41B | Sell |
16,839,515
-150,168
| -0.9% | -$48.8M | 0.1% | 167 |
|
|
2024
Q1 | $5.67B | Buy |
16,989,683
+60,304
| +0.4% | +$18.4M | 0.11% | 163 |
|
|
2023
Q4 | $4.58B | Sell |
16,929,379
-200,238
| -1% | -$49.5M | 0.1% | 185 |
|
|
2023
Q3 | $4.21B | Sell |
17,129,617
-352,641
| -2% | -$96.5M | 0.1% | 183 |
|
|
2023
Q2 | $5.31B | Sell |
17,482,258
-406,436
| -2% | -$113M | 0.13% | 139 |
|
|
2023
Q1 | $4.72B | Sell |
17,888,694
-58,024
| -0.3% | -$14.7M | 0.12% | 151 |
|
|
2022
Q4 | $4.31B | Sell |
17,946,718
-141,715
| -0.8% | -$31.7M | 0.12% | 174 |
|
|
2022
Q3 | $3.32B | Sell |
18,088,433
-528,820
| -3% | -$105M | 0.1% | 209 |
|
|
2022
Q2 | $3.13B | Sell |
18,617,253
-496,245
| -3% | -$107M | 0.09% | 230 |
|
|
2022
Q1 | $4.79B | Buy |
19,113,498
+181,855
| +1% | +$45.7M | 0.11% | 170 |
|
|
2021
Q4 | $4.86B | Sell |
18,931,643
-1,055,035
| -5% | -$258M | 0.11% | 168 |
|
|
2021
Q3 | $4.85B | Sell |
19,986,678
-997,934
| -5% | -$244M | 0.12% | 146 |
|
|
2021
Q2 | $4.34B | Sell |
20,984,612
-30,265
| -0.1% | -$6.17M | 0.11% | 170 |
|
|
2021
Q1 | $3.96B | Buy |
21,014,877
+228,351
| +1% | +$40.3M | 0.11% | 166 |
|
|
2020
Q4 | $3.42B | Sell |
20,786,526
-84,374
| -0.4% | -$12.3M | 0.1% | 189 |
|
|
2020
Q3 | $2.6B | Sell |
20,870,900
-134,016
| -0.6% | -$16.6M | 0.09% | 221 |
|
|
2020
Q2 | $2.04B | Sell |
21,004,916
-405,682
| -2% | -$42.2M | 0.07% | 288 |
|
|
2020
Q1 | $1.92B | Buy |
21,410,598
+417,842
| +2% | +$54.1M | 0.08% | 239 |
|
|
2019
Q4 | $3.1B | Buy |
20,992,756
+62,510
| +0.3% | +$8.39M | 0.11% | 188 |
|
|
2019
Q3 | $2.52B | Buy |
20,930,246
+65,225
| +0.3% | +$8.43M | 0.09% | 226 |
|
|
2019
Q2 | $2.82B | Buy |
20,865,021
+88,231
| +0.4% | +$11.2M | 0.11% | 188 |
|
|
2019
Q1 | $2.71B | Buy |
20,776,790
+183,284
| +0.9% | +$24.6M | 0.11% | 184 |
|
|
2018
Q4 | $2.56B | Buy |
20,593,506
+677,146
| +3% | +$90.9M | 0.12% | 171 |
|
|
2018
Q3 | $2.77B | Buy |
19,916,360
+66,808
| +0.3% | +$8.32M | 0.11% | 178 |
|
|
2018
Q2 | $2.04B | Buy |
19,849,552
+475,507
| +2% | +$48.1M | 0.09% | 237 |
|
|
2018
Q1 | $1.88B | Buy |
19,374,045
+56,951
| +0.3% | +$5.53M | 0.08% | 252 |
|
|
2017
Q4 | $1.7B | Sell |
19,317,094
-350,755
| -2% | -$28.2M | 0.07% | 297 |
|
|
2017
Q3 | $1.57B | Sell |
19,667,849
-50,401
| -0.3% | -$4.05M | 0.07% | 302 |
|
|
2017
Q2 | $1.72B | Buy |
19,718,250
+141,258
| +0.7% | +$12M | 0.08% | 253 |
|
|
2017
Q1 | $1.74B | Buy |
19,576,992
+361,027
| +2% | +$30.1M | 0.09% | 241 |
|
|
2016
Q4 | $1.42B | Sell |
19,215,965
-387,412
| -2% | -$29M | 0.08% | 272 |
|
|
2016
Q3 | $1.48B | Sell |
19,603,377
-35,387
| -0.2% | -$2.71M | 0.09% | 249 |
|
|
2016
Q2 | $1.51B | Sell |
19,638,764
-27,883
| -0.1% | -$2.2M | 0.09% | 233 |
|
|
2016
Q1 | $1.53B | Buy |
19,666,647
+1,053,560
| +6% | +$73.6M | 0.1% | 213 |
|
|
2015
Q4 | $1.26B | Buy |
18,613,087
+84,850
| +0.5% | +$5.92M | 0.08% | 253 |
|
|
2015
Q3 | $1.43B | Buy |
18,528,237
+1,524,514
| +9% | +$135M | 0.1% | 201 |
|
|
2015
Q2 | $1.54B | Buy |
17,003,723
+197,574
| +1% | +$15.8M | 0.1% | 196 |
|
|
2015
Q1 | $1.26B | Buy |
16,806,149
+4,776,247
| +40% | +$343M | 0.09% | 255 |
|
|
2014
Q4 | $883M | Buy |
12,029,902
+433,467
| +4% | +$30.5M | 0.06% | 344 |
|
|
2014
Q3 | $818M | Buy |
11,596,435
+150,085
| +1% | +$9.92M | 0.06% | 334 |
|
|
2014
Q2 | $645M | Buy |
11,446,350
+478,421
| +4% | +$25.2M | 0.05% | 424 |
|
|
2014
Q1 | $576M | Buy |
10,967,929
+300,458
| +3% | +$15M | 0.05% | 438 |
|
|
2013
Q4 | $509M | Buy |
10,667,471
+1,805,142
| +20% | +$83.4M | 0.04% | 465 |
|
|
2013
Q3 | $379M | Buy |
8,862,329
+352,350
| +4% | +$13.8M | 0.04% | 533 |
|
|
2013
Q2 | $307M | Buy |
+8,509,979
| New | +$329M | 0.03% | 579 |
|
Other funds holding HCA
Vanguard Group's HCA Position: Q4 2025 in Review
Vanguard Group reduced its HCA Healthcare (HCA) stake by 1.2% in Q4 2025, selling an estimated $82.9M and leaving 14,716,173 shares worth $6.87B. The position accounts for 0.1% of the portfolio, ranked #176.
Vanguard Group first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. 1,395 funds tracked by Wall St. Rank hold HCA as of Q4 2025.
- Vanguard Group held 14,716,173 shares of HCA Healthcare worth $6.87B as of Q4 2025.
- Vanguard Group sold 178,502 HCA Healthcare shares in Q4 2025, an estimated $82.9M.
- HCA Healthcare made up 0.1% of Vanguard Group's portfolio in Q4 2025, its #176 holding.
- Vanguard Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
- 1,395 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.